Regeneron Pharmaceuticals, Inc. v. Merus B.V.
Plaintiff: Regeneron Pharmaceuticals, Inc.
Defendant: Merus B.V.
Case Number: 1:2014cv01650
Filed: March 11, 2014
Court: US District Court for the Southern District of New York
Office: Foley Square Office
County: Westchester
Presiding Judge: Katherine B. Forrest
Nature of Suit: Patent
Cause of Action: 35 U.S.C. ยง 145
Jury Demanded By: Plaintiff

Available Case Documents

The following documents for this case are available for you to view or download:

Date Filed Document Text
March 26, 2018 Opinion or Order Filing 468 OPINION & ORDER re: 425 MOTION for Attorney Fees, Experts' Fees, and Costs. For the foregoing reasons, the Court GRANTS Merus's motion for attorney fees, expert fees, and costs. As Merus has not yet submitted a detailed explanation of those costs, the Court will not at this time take up the issue of the amount of such award. The parties are ordered to confer on a schedule for submission of those records and Regeneron's opposition, if any will be filed. The parties shall file a letter to the Court outlining that schedule not later than fourteen days from the issuance of this Opinion. SO ORDERED. (Signed by Judge Katherine B. Forrest on 3/26/2018) (anc)
November 2, 2015 Opinion or Order Filing 423 OPINION AND ORDER: For the reasons set forth in this Opinion and order, the Court finds that Regeneron has engaged in inequitable conduct in connection with prosecution of the 018 Patent. The parties shall confer on a form of order of judgment and file either a joint proposed order or competing proposed orders within fourteen (14) days. The Clerk of Court is directed to terminate this action. (Signed by Judge Katherine B. Forrest on 11/2/2015) (jp)
November 21, 2014 Opinion or Order Filing 210 OPINION & ORDER(CLAIM CONSTRUCTION): The Court's determinations as to claim construction are as set forth above. (Signed by Judge Katherine B. Forrest on 11/21/2014) (mro)
June 19, 2014 Opinion or Order Filing 71 OPINION & ORDER re: 40 MOTION to Dismiss Plaintiff Regeneron's Complaint for Patent Infringement filed by Merus B.V. Merus's motion to dismiss is hereby DENIED. The Clerk of Court is directed to terminate the motion at ECF No. 40. The parties are reminded that a status conference is scheduled to occur on July 24, 2014 at 12:00 p.m. (Signed by Judge Katherine B. Forrest on 6/18/2014) (tro)
Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System

Search for this case: Regeneron Pharmaceuticals, Inc. v. Merus B.V.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Regeneron Pharmaceuticals, Inc.
Represented By: Susan E. Brune
Represented By: Marshall Alan Camp
Represented By: Morgan Chu
Represented By: David I. Gindler
Represented By: Josh B. Gordon
Represented By: Andrew Krause
Represented By: Richard Krebs
Represented By: Charles Anthony Michael
Represented By: Jason George Sheasby
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Merus B.V.
Represented By: Patricia Ann Carson
Represented By: Peter Brian Silverman
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?